Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 12, 2022
Accession Number: 0001140361-22-025737
Submission Type: POS AM
CIK: 0001724344
Company Name: Entasis Therapeutics Holdings Inc.
File Number: 333-241683